๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Level Biotechnology Inc. (TPEX:3118)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
28.40
-0.50 (-1.73%)
Nov 20, 2026, 1:15 PM CST

Level Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
695.3736.59731.35660.61593.01677.28
Revenue Growth
-7.70%0.72%10.71%11.40%-12.44%0.71%
Gross Profit
240.03257.7237.13219.55202.59232.5
Operating Income
68.2283.5575.3267.5564.978.96
Net Income
64.5579.764.8162.9158.4768.18
Earnings Per Share
1.982.441.991.931.792.09
EPS Growth
-20.12%22.61%3.11%7.82%-14.35%17.42%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Instrument and Equipment Trading
239.73216.44163.86134.77156.28
Entrusted Biotechnology Service Sales
126.86136.76112.1699.63110.27
Reagent Consumable Materials Trading
370.01378.15384.6358.61410.72
Total
736.59731.35660.61593.01677.28

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
201.91210.34252.78467.41463.5472.96
Total Debt
7.787.9812.6813.4112.5713.18
Net Cash (Debt)
194.13202.36240.1453.99450.92459.78
Net Cash Growth
9.31%-15.72%-47.11%0.68%-1.93%26.15%
Net Cash Per Share
5.946.197.3513.9013.8014.08

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
102.0559.6164.170.2165.07155.95
Capital Expenditures
-14.4-32.67-223.68-7.67-6.74-9.16
Free Cash Flow
87.6526.94-159.5862.5458.33146.8
Free Cash Flow Growth
---7.22%-60.26%81.93%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
34.52%34.98%32.42%33.23%34.16%34.33%
Operating Margin
9.81%11.34%10.30%10.23%10.95%11.66%
Pretax Margin
11.48%13.25%11.09%11.91%12.34%12.53%
Profit Margin
9.28%10.82%8.86%9.52%9.86%10.07%
FCF Margin
12.61%3.66%-21.82%9.47%9.84%21.67%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
2.2002.2001.8001.7001.7001.900
Dividend Per Share Growth
22.22%22.22%5.88%0%-10.53%18.75%
Dividend Yield
7.75%6.67%5.63%5.58%6.15%6.34%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.3413.4416.0215.7115.3514.26
P/FCF Ratio
10.5239.75-15.8015.386.62
PS Ratio
1.331.451.421.501.511.44